ESR1 and breast cancer: While the rate of ER expression in breast carcinomas from Tanzanian women was low compared to either American population, approximately half of all tumors in the Tanzanian group were ER-positive, indicating that a significant proportion of Tanzanian breast cancer patients would benefit from hormonal therapy.